Boothbay Fund Management, LLC Cyclerion Therapeutics, Inc. Transaction History

Boothbay Fund Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.47 - $1.29 $23,857 - $65,481	-50,761 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.73 - $4.13 $44,269 - $66,972	-16,216 Reduced 24.21%	50,761 $156,000
Q2 2021 Aug 16, 2021	BUY	$2.18 - $4.29 $71,634 - $140,969	32,860 Added 96.32%	66,977 $261,000
Q1 2021 May 17, 2021	BUY	$2.69 - $5.12 $91,774 - $174,679	34,117 New	34,117 $95,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $126M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.